Figure 7
From: Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas
Correlations of serum anti-FLNC autoantibody concentration measured by ELISA and survival of glioma patients. Kaplan-Meier survival curves of glioma patients show that a group having higher values of serum anti-FLNC autoantibody (≥0.31) survived significantly longer than the other group with lower values (A) in all glioma patients (p = 0.0040), (B) in low-grade glioma patients (p = 0.0070), (C) and in high-grade glioma patients (p = 0.0310).